Nisa Investment Advisors
RCEL icon

Nisa Investment Advisors’s Avita Medical RCEL Stock Holding History

Nisa Investment Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384 Hold
93
– – ﹤0.01% 2976
2026
Q1 		$344 Buy
+93
New +$390 ﹤0.01% 2911
2025
Q2 		– Sell
-1,375
Closed -$11.2K – 3081
2025
Q1 		$11.2K Buy
1,375
+1,212
+744% +$11.3K ﹤0.01% 2070
2024
Q4 		$2.09K Hold
163
– – ﹤0.01% 2477
2024
Q3 		$1.75K Buy
163
+148
+987% +$1.39K ﹤0.01% 2428
2024
Q2 		$119 Sell
15
-31
-67% -$295 ﹤0.01% 2867
2024
Q1 		$737 Buy
46
+32
+229% +$518 ﹤0.01% 2425
2023
Q4 		$192 Buy
+14
New +$160 ﹤0.01% 2564
2022
Q2 		– Sell
-1,700
Closed -$14K – 2488
2022
Q1 		$14K Buy
+1,700
New +$15.7K ﹤0.01% 2139
2021
Q4 		– Sell
-2,500
Closed -$44K – 2304
2021
Q3 		$44K Hold
2,500
– – ﹤0.01% 1963
2021
Q2 		$51K Buy
+2,500
New +$49.3K ﹤0.01% 1938

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nisa Investment Advisors's RCEL Position: Q2 2026 in Review

Nisa Investment Advisors held its Avita Medical (RCEL) position steady in Q2 2026 at 93 shares worth $384. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

Nisa Investment Advisors first reported a position in RCEL in Q2 2021 and has held it in 11 quarters since. The position peaked at $51K in Q2 2021. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Nisa Investment Advisors held 93 shares of Avita Medical worth $384 as of Q2 2026.
  • Nisa Investment Advisors left its Avita Medical share count unchanged in Q2 2026.
  • Avita Medical made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2976 holding.
  • Nisa Investment Advisors first reported a position in Avita Medical in Q2 2021 and has held it in 11 quarters since.
  • Nisa Investment Advisors's Avita Medical position peaked at $51K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.